{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:31:09Z","timestamp":1792812669233,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jns.2025.125692","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:28:32Z","timestamp":1764894512000},"page":"125692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factors influencing the long-term maintenance of spasticity neurotoxin treatment"],"prefix":"10.1016","volume":"480","author":[{"given":"Mallory L.","family":"Hacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheffield","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Slatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli A.","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Zarghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2025.125692_bb0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.20285","article-title":"Pathophysiology of spastic paresis. II: emergence of muscle overactivity","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jns.2025.125692_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jnnp.2004.035972","article-title":"Clinical management of spasticity","volume":"76","author":"Thompson","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2025.125692_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pmrj.2014.09.021","article-title":"Botulinum toxin injection techniques for the management of adult spasticity","volume":"7","author":"Walker","year":"2015","journal-title":"PM R"},{"key":"10.1016\/j.jns.2025.125692_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4737","article-title":"The management of spasticity in adults","volume":"349","author":"Nair","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jns.2025.125692_bb0025","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-017-3078-3","article-title":"Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study","volume":"38","author":"Latino","year":"2017","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2025.125692_bb0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5603\/PJNNS.a2020.0021","article-title":"Cervical dystonia \u2014 improving the effectiveness of botulinum toxin therapy","volume":"54","author":"Ty\u015blerowicz","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"issue":"10","key":"10.1016\/j.jns.2025.125692_bb0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/toxins14100675","article-title":"Reasons and determinants of BoNT-A treatment discontinuation in patients living with spasticity: a 10-year retrospective analysis","volume":"14","author":"Cinone","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"11","key":"10.1016\/j.jns.2025.125692_bb0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/toxins14110774","article-title":"Persistence with botulinum toxin treatment for spasticity symptoms in multiple sclerosis","volume":"14","author":"Novarella","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"03","key":"10.1016\/j.jns.2025.125692_bb0045","doi-asserted-by":"crossref","DOI":"10.4172\/2376-0389.1000148","article-title":"S, \u201cinterest of botulinum toxin for treatment of spasticity in multiple sclerosis,\u201d","volume":"02","author":"Petrilli","year":"2015","journal-title":"J Mult Scler (Foster City)"},{"issue":"20","key":"10.1016\/j.jns.2025.125692_bb0050","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1212\/WNL.0000000000009444","article-title":"Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy","volume":"94","author":"Walter","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.125692_bb0055","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1524-4725.2006.32327.x","article-title":"Repeated botulinum toxin a injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients","volume":"33, no. 1 Spec No","author":"Rzany","year":"2007","journal-title":"Dermatologic Surg."},{"issue":"2","key":"10.1016\/j.jns.2025.125692_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3138\/ptc.2014-07","article-title":"Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments","volume":"67","author":"Cheung","year":"2015","journal-title":"Physiother. Can."},{"issue":"11","key":"10.1016\/j.jns.2025.125692_bb0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sc.2016.46","article-title":"Pain, spasticity and quality of life in individuals with traumatic spinal cord injury in Denmark","volume":"54","author":"Andresen","year":"2016","journal-title":"Spinal Cord"},{"issue":"10","key":"10.1016\/j.jns.2025.125692_bb0070","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/01.STR.28.10.1876","article-title":"Is the EuroQol a valid measure of health-related quality of life after stroke?","volume":"28","author":"Dorman","year":"1997","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.jns.2025.125692_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011157","article-title":"Impact of integrated upper limb spasticity management including botulinum toxin a on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)","volume":"6","author":"Turner-Stokes","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jns.2025.125692_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/jisprm.jisprm_47_19","article-title":"ULIS (upper limb international spasticity), a 10-year odyssey","volume":"2","author":"Turner-Stokes","year":"2019","journal-title":"J Int Soc Phys Rehabil Med"},{"key":"10.1016\/j.jns.2025.125692_bb0085","article-title":"Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin a: findings from the prospective, observational upper limb international spasticity (ULIS-III) cohort study","volume":"53, no. 2","author":"Turner-Stokes","year":"2021","journal-title":"J. Rehabil. Med."},{"issue":"5","key":"10.1016\/j.jns.2025.125692_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/0972-2327.83099","article-title":"Guidelines for the use of botulinum toxin in movement disorders and spasticity","volume":"14","author":"Jabeen","year":"2011","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2025.125692_bb0095","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/09638288.2016.1198432","article-title":"An international survey of patients living with spasticity","volume":"39","author":"Barnes","year":"2017","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.jns.2025.125692_bb0100","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin a: an international group consensus","volume":"53, no. 1","author":"Francisco","year":"2021","journal-title":"J. Rehabil. Med."},{"issue":"5","key":"10.1016\/j.jns.2025.125692_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2340\/16501977-2231","article-title":"Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: a cohort study","volume":"49","author":"Picelli","year":"2017","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.jns.2025.125692_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.570671","article-title":"Botulinum neurotoxin-a injection in adult cervical dystonia and spastic paresis: results from the INPUT (INjection practice, usage and training) survey","volume":"11","author":"Chung","year":"2020","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2025.125692_bb0115","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.clinthera.2019.09.007","article-title":"Management of Spastic Paresis and Cervical Dystonia: access to therapeutic innovations through an international program of practical courses","volume":"41","author":"Colosimo","year":"2019","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.jns.2025.125692_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12874-015-0016-z","article-title":"Exploring physician specialist response rates to web-based surveys","volume":"15","author":"Cunningham","year":"2015","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jns.2025.125692_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.946500","article-title":"Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: results from a prospective ethnographic study","volume":"13","author":"Jacinto","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2025.125692_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/PPA.S115090","article-title":"The state of multiple sclerosis: current insight into the patient\/health care provider relationship, treatment challenges, and satisfaction","volume":"11","author":"Tintor\u00e9","year":"2017","journal-title":"Patient Prefer. Adherence"},{"issue":"12","key":"10.1016\/j.jns.2025.125692_bb0135","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00415-012-6510-x","article-title":"Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value","volume":"259","author":"Zoons","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2025.125692_bb0140","article-title":"Treatment patterns and healthcare costs among patients with stroke and spasticity: a 2-year longitudinal study","author":"Hull","year":"2024","journal-title":"Neurol Ther"},{"issue":"105","key":"10.1016\/j.jns.2025.125692_bb0145","first-page":"298","article-title":"Frequency of side effects after botulinum toxin a injections in neurology, rehabilitation and gastroenterology","volume":"18","author":"S\u0142awek","year":"2005","journal-title":"Pol. Merkur. Lekarski"},{"issue":"1","key":"10.1016\/j.jns.2025.125692_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11010021","article-title":"Central effects of botulinum neurotoxin-evidence from human studies","volume":"11","author":"Weise","year":"2019","journal-title":"Toxins (Basel)"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25023123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:20:11Z","timestamp":1767936011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25023123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"alternative-id":["S0022510X25023123"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.125692","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing the long-term maintenance of spasticity neurotoxin treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.125692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125692"}}